Source: Annual Congress 2004 - Molecular biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Laule-Kilian, L. Bubendorf, M. Pless, M. Mirlacher, M. Tamm, M. H. Brutsche (Basle, Switzerland). Tailored therapy for non-small cell lung cancer – it is difficult to get enough good quality mRNA from bronchoscopic biopsies. Eur Respir J 2004; 24: Suppl. 48, 4323

Member's Comments

No comment yet.

Related content which might interest you: Lung function and quality of life after surgical treatment of non-small cell lung cancer – preliminary results Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008 Bronchoscopic treatment of inoperable nonsmall cell lung cancer Source: Eur Respir Rev, 29 (158) 200035; 10.1183/16000617.0035-2020 Year: 2020 Bronchoscopic intratumoural therapies for non-small cell lung cancer Source: Eur Respir Rev, 29 (156) 200028; 10.1183/16000617.0028-2020 Year: 2020 The evaluation of surgical results in pT0-pT1 non-small cell lung carcinoma after induction therapy Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 Improving standards in flexible bronchoscopy for lung cancer Source: Eur Respir J 2011; 37: 895-901 Year: 2011 Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 378s Year: 2001 The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Long-term results of surgically treated non-small cell lung cancer patients depending on the protocol of preoperative N-staging Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 Completion pneumectomy is a safe procedure for non-small cell lung cancer Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019 Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives Source: Eur Respir Rev 2011; 20: 45-52 Year: 2011 Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer Source: Eur Respir J 2013; 42: 1357-1364 Year: 2013 Early recurrence in complete resected non-small cell lung cancer patients Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 Salvage surgery in patients with locally advanced non-small cell lung cancer – outcomes and longtime results Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Surgical and nonsurgical approaches to small-size nonsmall cell lung cancer Source: Eur Respir J 2014; 44: 483-494 Year: 2014 Surgical treatment of nonsmall cell lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=170 Year: 2001 Long-term survival after surgical resection for non-small cell lung cancer Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017